International. Camfil and Sinopharm Gepteck announced the joint launch of high-efficiency digital air supply units. Sinopharm is the largest pharmaceutical and healthcare group under the State Council's State Property Asset Management and Supervision Commission (SASAC) in China, with the core business of pharmaceutical distribution, scientific research, and manufacturing of medical and biotechnological products.
The initiative will focus on the application limitations of traditional air supply units and set new milestones in the clean air conditioning system in the biomedical industry.
With the introduction of the "Fourteenth Five-Year Plan for the Biomedical Industry" and relevant supporting policies, China's biomedical industry will usher in a "golden decade". In recent years, the state has intensified its support for innovation in biotechnology and the development of the biological industry, which has maintained the rapid and growing momentum of China's biopharmaceutical industry; as such, you will see an ever-larger pharmaceutical market in the future. In addition, the COVID-19 outbreak has boosted demand for vaccines and other products, which will further expand the market of China's biopharmaceutical industry.
In recent years, Sinopharm Gepteck has established an R&D-oriented development path and has made "clean air conditioning compliance and energy saving" its key research direction. It found the defects and deficiencies in the operation of ventilation systems and hoped to develop a patented product "high-efficiency digital air supply unit".
Camfil's expertise in the field of high-efficiency air filtration products and life sciences has been highly recognized by Sinopharm Gepteck. After in-depth communication and market analysis, the two sides reached strategic cooperation and successfully developed high-efficiency digital air supply units. The high-efficiency digital air supply unit is applicable in high-risk products with rigorous cleaning requirements in cell therapy such as vaccines, biologics, sterile preparations, sterile APIs, blood products, CAR-T, etc.
It can perform real-time air volume monitoring and quick response adjustment, performs in-line air volume balance and pressure difference control, reduces compliance risks and resolves the intractable pressure difference in the industry. You can achieve an accurate air supply, reduce energy waste every day, shorten the purification time, and achieve preventive maintenance by trend analysis, which really realizes the energy savings and intelligence.
On May 10, Sinopharm Gepteck and Camfil Group China successfully held the strategic cooperation ceremony and joint launch of the high-efficiency digital air supply unit at the Camfil stand of the 60th China International Pharmaceutical Machinery Expo.
